Stanislav Tuček
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Stanislav Tuček has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Pavel Michal
3 shared publicationsMichaela Lysíková
11Institute of Physiology, Academy of Sciences of the Czech Republic, Vídeňská 1083, 14220 Prague, Czech Republic
2 shared publications- Viktorie Vlachova
Department of Cellular Neurophysiology, Institute of Physiology, Czech Academy of Sciences, Prague 4, Czech Republic
2 shared publications - Jan Jakubík
Department of Neurochemistry, Institute of Physiology Czech Academy of Sciences Prague Czech Republic
1 shared publication - Jaromir Myslivecek
Institute of Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
1 shared publication Květa Fuksová
22Central Radioisotope Laboratory, First Medical Faculty of Charles University, Na bojišti 3, 12108 Prague, Czech Republic
1 shared publication
Latest Publications
- 1 April 2002
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 23 (4) , 171-176
Modelling the consequences of receptor–G-protein promiscuity
- 1 April 2002
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 23 (4) , 171-176
Modelling the consequences of receptor–G-protein promiscuity
- 1 April 2001
- Published by Elsevier in Life Sciences
- Vol. 68 (22-23) , 2501-2510
Dual effects of muscarinic M2 receptors on the synthesis of cyclic AMP in CHO cells
- 1 April 2001
- Published by Elsevier in Life Sciences
- Vol. 68 (22-23) , 2501-2510
Dual effects of muscarinic M2 receptors on the synthesis of cyclic AMP in CHO cells
- 1 March 2001
- Published by Wiley in British Journal of Pharmacology
- Vol. 132 (6) , 1217-1228
Dual effects of muscarinic M2 acetylcholine receptors on the synthesis of cyclic AMP in CHO cells: dependence on time, receptor density and receptor agonists
Muscarinic M2 receptors normally inhibit the production of cyclic AMP via Gi proteins, but a stimulatory component occurs in their effect at high agonist concentrations, believed to be based on the activation of Gs proteins. We investigated the conditions which determine the occurrence and extent of the stimulatory component in CHO cells stably expressing muscarinic M2 receptors. Biphasic concentration‐response curves (decline followed by return towards control values) were obtained after 10 min incubation with carbachol, oxotremorine‐M, acetylcholine, arecoline and arecaidine propargyl ester, but the upward phase was missing with oxotremorine, methylfurmethide, furmethide and pentylthio‐TZTP. Shortening the incubation favoured the occurrence of the stimulatory component. Carbachol (1 mM) and oxotremorine‐M (1 mM) brought about net stimulation (above 100% of control) of cyclic AMP synthesis during 2 min incubations. The stimulatory components disappeared after the density of receptors had been lowered with oxyphenonium mustard. All agonists stimulated the synthesis of cyclic AMP in cells pretreated with pertussis toxin. Most differences between agonists regarding the stimulatory component of their effect on cyclic AMP synthesis could be explained by differences in their efficacy and the induced receptor internalization. We propose that the Gs‐mediated stimulatory component of the effect of muscarinic M2 receptors on cyclic AMP synthesis only occurs if the density of activated receptors is high enough to saturate the Gi proteins and proportionate to the receptors' low affinity for the Gs proteins. It tends to be abolished by receptor internalization. British Journal of Pharmacology (2001) 132, 1217–1228; doi:10.1038/sj.bjp.0703931
- 1 March 2001
- Published by Wiley in British Journal of Pharmacology
- Vol. 132 (6) , 1217-1228
Dual effects of muscarinic M2 acetylcholine receptors on the synthesis of cyclic AMP in CHO cells: dependence on time, receptor density and receptor agonists
Muscarinic M2 receptors normally inhibit the production of cyclic AMP via Gi proteins, but a stimulatory component occurs in their effect at high agonist concentrations, believed to be based on the activation of Gs proteins. We investigated the conditions which determine the occurrence and extent of the stimulatory component in CHO cells stably expressing muscarinic M2 receptors. Biphasic concentration‐response curves (decline followed by return towards control values) were obtained after 10 min incubation with carbachol, oxotremorine‐M, acetylcholine, arecoline and arecaidine propargyl ester, but the upward phase was missing with oxotremorine, methylfurmethide, furmethide and pentylthio‐TZTP. Shortening the incubation favoured the occurrence of the stimulatory component. Carbachol (1 mM) and oxotremorine‐M (1 mM) brought about net stimulation (above 100% of control) of cyclic AMP synthesis during 2 min incubations. The stimulatory components disappeared after the density of receptors had been lowered with oxyphenonium mustard. All agonists stimulated the synthesis of cyclic AMP in cells pretreated with pertussis toxin. Most differences between agonists regarding the stimulatory component of their effect on cyclic AMP synthesis could be explained by differences in their efficacy and the induced receptor internalization. We propose that the Gs‐mediated stimulatory component of the effect of muscarinic M2 receptors on cyclic AMP synthesis only occurs if the density of activated receptors is high enough to saturate the Gi proteins and proportionate to the receptors' low affinity for the Gs proteins. It tends to be abolished by receptor internalization. British Journal of Pharmacology (2001) 132, 1217–1228; doi:10.1038/sj.bjp.0703931
- 1 July 1999
- Published by Wiley in British Journal of Pharmacology
- Vol. 127 (5) , 1240-1246
Subtype‐selective inhibition of [methyl‐3H]‐N‐methylscopolamine binding to muscarinic receptors by α‐truxillic acid esters
Seven esters of α‐truxillic acid have been synthesized: bis‐3‐piperidylpropyl ester and its quaternary bis‐N‐ethyl derivative, bis‐N‐diethylaminopropyl ester and its quaternary bis‐N‐methyl derivative, and bis‐4‐piperidylbutyl ester and its quaternary bis‐N‐methyl and bis‐N‐ethyl derivatives. All esters inhibited the specific binding of muscarinic receptor antagonist [methyl‐3H]‐N‐methylscopolamine ([3H]‐NMS) to muscarinic receptors in membranes of CHO cell lines stably expressing the human gene for the M1, M2, M3 or M4 subtype of muscarinic receptors. All esters displayed the highest potency at the M2 and the lowest potency at the M3 receptor subtype. In experiments performed on the M2 muscarinic receptor subtype, the affinity between the receptors and the esters was greatly increased when the concentration of ions was diminished. The highest affinities were found for the tertiary bis‐3‐piperidylpropyl and bis‐4‐piperidylbutyl aminoesters (equilibrium dissociation constants of 52 and 179 pM, respectively, in the low ionic strength medium). All investigated esters slowed down the dissociation of [3H]‐NMS from the M2 muscarinic receptor subtype. [3H]‐NMS dissociation from the M1, M3 and M4 muscarinic receptor subtypes was investigated in experiments with the bis‐4‐piperidylbutyl aminoester and also found to be decelerated. It is concluded that the esters of α‐truxillic acid act as M2‐selective allosteric modulators of muscarinic receptors and that, by their potency, the tertiary bis‐3‐piperidylpropyl and bis‐4‐piperidylbutyl aminoesters surpass the other known allosteric modulators of these receptors. British Journal of Pharmacology (1999) 127, 1240–1246; doi:10.1038/sj.bjp.0702646
- 1 July 1999
- Published by Wiley in British Journal of Pharmacology
- Vol. 127 (5) , 1240-1246
Subtype‐selective inhibition of [methyl‐3H]‐N‐methylscopolamine binding to muscarinic receptors by α‐truxillic acid esters
Seven esters of α‐truxillic acid have been synthesized: bis‐3‐piperidylpropyl ester and its quaternary bis‐N‐ethyl derivative, bis‐N‐diethylaminopropyl ester and its quaternary bis‐N‐methyl derivative, and bis‐4‐piperidylbutyl ester and its quaternary bis‐N‐methyl and bis‐N‐ethyl derivatives. All esters inhibited the specific binding of muscarinic receptor antagonist [methyl‐3H]‐N‐methylscopolamine ([3H]‐NMS) to muscarinic receptors in membranes of CHO cell lines stably expressing the human gene for the M1, M2, M3 or M4 subtype of muscarinic receptors. All esters displayed the highest potency at the M2 and the lowest potency at the M3 receptor subtype. In experiments performed on the M2 muscarinic receptor subtype, the affinity between the receptors and the esters was greatly increased when the concentration of ions was diminished. The highest affinities were found for the tertiary bis‐3‐piperidylpropyl and bis‐4‐piperidylbutyl aminoesters (equilibrium dissociation constants of 52 and 179 pM, respectively, in the low ionic strength medium). All investigated esters slowed down the dissociation of [3H]‐NMS from the M2 muscarinic receptor subtype. [3H]‐NMS dissociation from the M1, M3 and M4 muscarinic receptor subtypes was investigated in experiments with the bis‐4‐piperidylbutyl aminoester and also found to be decelerated. It is concluded that the esters of α‐truxillic acid act as M2‐selective allosteric modulators of muscarinic receptors and that, by their potency, the tertiary bis‐3‐piperidylpropyl and bis‐4‐piperidylbutyl aminoesters surpass the other known allosteric modulators of these receptors. British Journal of Pharmacology (1999) 127, 1240–1246; doi:10.1038/sj.bjp.0702646
- 1 August 1998
- Published by Elsevier in Life Sciences
- Vol. 63 (13) , 1169-1182
Heterologous regulation of muscarinic and beta-adrenergic receptors in rat cardiomyocytes in culture
- 1 August 1998
- Published by Elsevier in Life Sciences
- Vol. 63 (13) , 1169-1182
Heterologous regulation of muscarinic and beta-adrenergic receptors in rat cardiomyocytes in culture